Rosuvastatin (Crestor) is used to treat several types of high cholesterol and to prevent heart disease. Learn about side effects, warnings, dosage, and more.

There is broad consensus that the overall body of evidence shows lowering LDL (low-density lipoprotein) cholesterol provides ...

Rosuvastatin calcium (Crestor; AstraZeneca), the seventh drug in the statin class, was approved by the US FDA in August 2003 for the reduction of cholesterol levels in patients with ...

Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney failure with replacement therapy, according to a study.Further, investigators found ...

Paris, France - Investigators assessing the effects of different statins on lipid profile in hypercholesterolemic patients with and without metabolic syndrome have found that rosuvastatin (Crestor ...

Study assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic dyslipidemia.

Among those assigned to rosuvastatin, the median LDL cholesterol level at 12 months was 55 mg per deciliter (1.4 mmol per liter) (interquartile range, 44 to 72 [1.1 to 1.9]), and the median high ...

Rosuvastatin/ezetimibe is available as a once-daily tablet with dosages of 5 mg/10 mg, 10 mg/10 mg, 20 mg/10 mg and 40 mg/10 mg, according to the release.

Treatment with the anticholesterol medicine rosuvastatin calcium did not reduce the risk of fracture among men and women who had elevated levels of an inflammatory biomarker, according to a report ...

A total of 5011 patients at least 60 years of age with New York Heart Association class II, III, or IV ischemic, systolic heart failure were randomly assigned to receive 10 mg of rosuvastatin or ...

Review the side-effects of Rosuvastatin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority ...

Based on robust randomized trial data and meta-analyses, FAU experts conclude that statins – particularly rosuvastatin and ...